Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

2.

Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18-36 months of age.

Qadri F, Ahmed T, Ahmed F, Bradley Sack R, Sack DA, Svennerholm AM.

Vaccine. 2003 Jun 2;21(19-20):2394-403.

PMID:
12744870
3.

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.

Clemens JD, Sack DA, Harris JR, Chakraborty J, Neogy PK, Stanton B, Huda N, Khan MU, Kay BA, Khan MR, et al.

J Infect Dis. 1988 Aug;158(2):372-7.

PMID:
3042876
4.

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.

Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG.

Vaccine. 2005 Oct 17;23(43):5120-6.

PMID:
15982790
5.

Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli.

Sack RB, Santosham M, Froehlich JL, Medina C, Orskov F, Orskov I.

Am J Trop Med Hyg. 1984 May;33(3):460-6.

PMID:
6375407
6.

Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.

Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F.

Cochrane Database Syst Rev. 2013 Jul 5;(7):CD009029. doi: 10.1002/14651858.CD009029.pub2. Review.

PMID:
23828581
7.

[Examples for vaccines against diarrheal diseases--rotavirus and traveller's diarrhea].

Kollaritsch H, Wiedermann U.

Wien Med Wochenschr. 2007;157(5-6):102-6. Review. German.

PMID:
17427005
8.

A review of the current status of enteric vaccines.

Levine MM, Noriega F.

P N G Med J. 1995 Dec;38(4):325-31. Review.

PMID:
9522876
9.

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.

Savarino SJ, Hall ER, Bassily S, Brown FM, Youssef F, Wierzba TF, Peruski L, El-Masry NA, Safwat M, Rao M, El Mohamady H, Abu-Elyazeed R, Naficy A, Svennerholm AM, Jertborn M, Lee YJ, Clemens JD.

J Infect Dis. 1999 Jan;179(1):107-14.

PMID:
9841829
10.

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

McKenzie R, Bourgeois AL, Frech SA, Flyer DC, Bloom A, Kazempour K, Glenn GM.

Vaccine. 2007 May 4;25(18):3684-91. Epub 2007 Jan 23.

PMID:
17313998
11.

Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.

Jelinek T, Kollaritsch H.

Expert Rev Vaccines. 2008 Jul;7(5):561-7. doi: 10.1586/14760584.7.5.561. Review.

PMID:
18564011
12.

Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea.

Lundkvist J, Steffen R, J├Ânsson B.

J Travel Med. 2009 Jan-Feb;16(1):28-34. doi: 10.1111/j.1708-8305.2008.00270.x. Erratum in: J Travel Med. 2009 Mar-Apr;16(2):147.

13.

Vaccines for enterotoxigenic Escherichia coli: current status.

Boedeker EC.

Curr Opin Gastroenterol. 2005 Jan;21(1):15-9. Review.

PMID:
15687879
14.

Vaccines against traveler's diarrhoea and rotavirus disease - a review.

Wiedermann U, Kollaritsch H.

Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):2-8. Review.

PMID:
17131234
15.

Vaccines against enterotoxigenic Escherichia coli.

Svennerholm AM, Tobias J.

Expert Rev Vaccines. 2008 Aug;7(6):795-804. doi: 10.1586/14760584.7.6.795. Review.

PMID:
18665777
17.

Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method.

Clemens J, Savarino S, Abu-Elyazeed R, Safwat M, Rao M, Wierzba T, Svennerholm AM, Holmgren J, Frenck R, Park E, Naficy A.

J Infect Dis. 2004 Jun 15;189(12):2299-307. Epub 2004 May 25.

PMID:
15181579
18.
19.

Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea.

Svennerholm AM, Holmgren J, Sack DA.

Vaccine. 1989 Jun;7(3):196-8. Review.

PMID:
2675484
20.

Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.

Roland KL, Cloninger C, Kochi SK, Thomas LJ, Tinge SA, Rouskey C, Killeen KP.

Vaccine. 2007 Dec 12;25(51):8574-84. Epub 2007 Oct 26.

PMID:
18045752

Supplemental Content

Support Center